Steven Fakharzadeh
Johnson & Johnson (United States)(US)Janssen (United States)(US)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Health Systems, Economic Evaluations, Quality of Life, Hemophilia Treatment and Research, Autoimmune Bullous Skin Diseases
Most-Cited Works
- → The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An Outcome Instrument for Cutaneous Lupus Erythematosus(2005)490 cited
- → Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis(2015)365 cited
- → Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry(2017)156 cited
- → Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials(2011)140 cited
- → Protection against Pemphigus Foliaceus by Desmoglein 3 in Neonates(2000)128 cited
- → Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease‐based registry (PSOLAR)(2014)115 cited